• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TAFRO 综合征肾活检后应用激素和环孢素成功治疗 1 例报告

TAFRO syndrome with renal biopsy successfully treated with steroids and cyclosporine: a case report.

机构信息

Division of Kidney and Dialysis, Hyogo College of Medicine, 1-1 Mukogawa-cho, Nishinomiya City, Hyogo, 663-8501, Japan.

Division of Allergology and Rheumatology, Hyogo College of Medicine, Mukogawa-cho, Nishinomiya City, Hyogo, 663-8501, Japan.

出版信息

BMC Nephrol. 2022 Jul 23;23(1):262. doi: 10.1186/s12882-022-02886-5.

DOI:10.1186/s12882-022-02886-5
PMID:35870879
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9308189/
Abstract

BACKGROUND

TAFRO syndrome is an acute or subacute systemic inflammatory disease with no apparent cause, presenting with fever, generalized edema, thrombocytopenia, renal damage, anemia, and organ enlargement. Interleukin-6, vascular endothelial growth factor, and other cytokines are thought to be the etiologic agents that increase vascular permeability and cause the resulting organ damage. Only few reports of renal biopsy performed in patients with TAFRO syndrome exist.

CASE PRESENTATION

A 61-year-old woman, with a history of Sjogren's syndrome, was admitted to our hospital with anasarca and abdominal distension. Based on the clinical course and various laboratory findings, we diagnosed TAFRO syndrome. Renal biopsy revealed thrombotic microangiopathy, including endothelial cell swelling, subendothelial space expansion, and mesangiolysis. She was treated with oral prednisolone and cyclosporine, with consequent resolution of anasarca, pleural effusion, and ascites, and improvement in renal function and urinary findings. The patient's platelet count also normalized after 2 months of treatment.

CONCLUSIONS

Given that only few reports of improvement in the systemic symptoms of TAFRO syndrome using steroids and cyclosporine exist, our study investigating the relationship between the pathogenesis of TAFRO syndrome and renal disorders, as well as treatment methods, provides valuable insights.

摘要

背景

TAFRO 综合征是一种无明显病因的急性或亚急性全身性炎症性疾病,表现为发热、全身水肿、血小板减少、肾功能损害、贫血和器官肿大。白细胞介素-6、血管内皮生长因子等细胞因子被认为是增加血管通透性并导致相应器官损伤的致病因子。目前仅有少数关于 TAFRO 综合征患者行肾活检的报道。

病例介绍

一名 61 岁女性,有干燥综合征病史,因全身水肿和腹胀入院。根据临床经过和各种实验室检查结果,我们诊断为 TAFRO 综合征。肾活检显示血栓性微血管病,包括内皮细胞肿胀、内皮下腔扩张和系膜溶解。患者接受了口服泼尼松龙和环孢素治疗,随后全身水肿、胸腔积液和腹水消退,肾功能和尿液检查结果改善。治疗 2 个月后,患者的血小板计数也恢复正常。

结论

鉴于仅少数报道称使用类固醇和环孢素可改善 TAFRO 综合征的全身症状,我们的研究调查了 TAFRO 综合征的发病机制与肾脏疾病之间的关系以及治疗方法,提供了有价值的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e08/9308189/e87d9eef4c9e/12882_2022_2886_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e08/9308189/370700a5bf4c/12882_2022_2886_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e08/9308189/a6173cd65c01/12882_2022_2886_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e08/9308189/2fb8c9917cdb/12882_2022_2886_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e08/9308189/e87d9eef4c9e/12882_2022_2886_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e08/9308189/370700a5bf4c/12882_2022_2886_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e08/9308189/a6173cd65c01/12882_2022_2886_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e08/9308189/2fb8c9917cdb/12882_2022_2886_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e08/9308189/e87d9eef4c9e/12882_2022_2886_Fig4_HTML.jpg

相似文献

1
TAFRO syndrome with renal biopsy successfully treated with steroids and cyclosporine: a case report.TAFRO 综合征肾活检后应用激素和环孢素成功治疗 1 例报告
BMC Nephrol. 2022 Jul 23;23(1):262. doi: 10.1186/s12882-022-02886-5.
2
Pathological findings of progressive renal involvement in a patient with TAFRO syndrome.TAFRO综合征患者进行性肾脏受累的病理表现
CEN Case Rep. 2019 Nov;8(4):239-245. doi: 10.1007/s13730-019-00400-9. Epub 2019 May 10.
3
TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review.TAFRO 综合征致肾小球微血管病:病例报告并文献复习。
BMC Nephrol. 2019 Oct 17;20(1):375. doi: 10.1186/s12882-019-1574-9.
4
Thrombotic microangiopathy on kidney biopsy in a patient with TAFRO syndrome.TAFRO综合征患者肾活检显示血栓性微血管病。
CEN Case Rep. 2018 Nov;7(2):243-247. doi: 10.1007/s13730-018-0338-x. Epub 2018 May 15.
5
Case Report: A case of TAFRO syndrome with severe and prolonged thrombocytopenia: diagnostic pitfalls.病例报告:一例 TAFRO 综合征伴严重和持久血小板减少:诊断陷阱。
Front Immunol. 2023 Oct 13;14:1266187. doi: 10.3389/fimmu.2023.1266187. eCollection 2023.
6
Unexplained cause of thrombocytopenia, fever, anasarca and hypothyroidism: TAFRO syndrome with thrombotic microangiopathy renal histology.血小板减少症、发热、全身水肿和甲状腺功能减退的不明原因:伴有血栓性微血管病肾组织学的 TAFRO 综合征。
BMJ Case Rep. 2020 Jun 30;13(6):e234155. doi: 10.1136/bcr-2019-234155.
7
Kidney biopsy findings in two patients with TAFRO syndrome: case presentations and review of the literature.两名 TAFRO 综合征患者的肾活检结果:病例报告及文献复习。
BMC Nephrol. 2020 Nov 23;21(1):499. doi: 10.1186/s12882-020-02119-7.
8
A case of TAFRO syndrome after vaccination, successfully treated with cyclosporine.接种疫苗后发生 TAFRO 综合征 1 例,环孢素治疗成功。
BMC Nephrol. 2024 Jun 13;25(1):196. doi: 10.1186/s12882-024-03630-x.
9
Renal Pathologic Findings in TAFRO Syndrome: Is There a Continuum Between Thrombotic Microangiopathy and Membranoproliferative Glomerulonephritis? A Case Report and Literature Review.TAFRO 综合征的肾脏病理表现:血栓性微血管病与膜增生性肾小球肾炎之间是否存在连续性?病例报告及文献复习。
Front Immunol. 2019 Jun 28;10:1489. doi: 10.3389/fimmu.2019.01489. eCollection 2019.
10
Successful rituximab treatment of TAFRO syndrome with pathological findings of glomerular endothelial damage.利妥昔单抗成功治疗伴有肾小球内皮损伤病理表现的TAFRO综合征。
Clin Nephrol Case Stud. 2018 Jun 22;6:16-20. doi: 10.5414/CNCS109400. eCollection 2018.

引用本文的文献

1
Increase in Vascular Endothelial Growth Factor (VEGF) Expression and the Pathogenesis of iMCD-TAFRO.血管内皮生长因子(VEGF)表达增加与iMCD-TAFRO的发病机制
Biomedicines. 2024 Jun 14;12(6):1328. doi: 10.3390/biomedicines12061328.
2
A case of TAFRO syndrome after vaccination, successfully treated with cyclosporine.接种疫苗后发生 TAFRO 综合征 1 例,环孢素治疗成功。
BMC Nephrol. 2024 Jun 13;25(1):196. doi: 10.1186/s12882-024-03630-x.
3
TAFRO syndrome is associated with anti-SSA/Ro60 antibodies, in contrast to idiopathic castleman disease.

本文引用的文献

1
Renal histological continuum of TAFRO syndrome: A case report and literature review.TAFRO综合征的肾脏组织学连续变化:一例病例报告及文献综述
Clin Nephrol. 2022 Feb;97(2):121-128. doi: 10.5414/CN110290.
2
TAFRO Syndrome in a Kidney Transplant Recipient That Was Diagnosed on Autopsy: A Case Report.尸检确诊的肾移植受者的TAFRO综合征:一例报告
Front Med (Lausanne). 2021 Oct 4;8:747678. doi: 10.3389/fmed.2021.747678. eCollection 2021.
3
TAFRO Syndrome With Kidney Involvement: A Case Series of Patients With Kidney Biopsies.合并肾脏受累的TAFRO综合征:肾活检患者的病例系列
与特发性Castleman病相反,TAFRO综合征与抗SSA/Ro60抗体相关。
Sci Rep. 2024 Feb 5;14(1):2889. doi: 10.1038/s41598-024-53413-5.
4
Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-based Position Paper From an ad hoc Expert Panel.特发性多中心Castleman病管理中未满足的临床需求:来自一个特设专家小组的基于共识的立场文件
Hemasphere. 2023 May 23;7(6):e891. doi: 10.1097/HS9.0000000000000891. eCollection 2023 Jun.
Kidney Med. 2021 Jan 19;3(2):286-293. doi: 10.1016/j.xkme.2020.10.011. eCollection 2021 Mar-Apr.
4
The Clinical and Histopathological Feature of Renal Manifestation of TAFRO Syndrome.TAFRO综合征肾脏表现的临床和组织病理学特征
Kidney Int Rep. 2020 May 19;5(8):1172-1179. doi: 10.1016/j.ekir.2020.05.004. eCollection 2020 Aug.
5
TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review.TAFRO 综合征致肾小球微血管病:病例报告并文献复习。
BMC Nephrol. 2019 Oct 17;20(1):375. doi: 10.1186/s12882-019-1574-9.
6
Association between the expression of vascular endothelial growth factors and metabolic syndrome or its components: a systematic review and meta-analysis.血管内皮生长因子表达与代谢综合征及其组分之间的关联:一项系统评价和Meta分析
Diabetol Metab Syndr. 2018 Aug 3;10:62. doi: 10.1186/s13098-018-0363-0. eCollection 2018.
7
Successful rituximab treatment of TAFRO syndrome with pathological findings of glomerular endothelial damage.利妥昔单抗成功治疗伴有肾小球内皮损伤病理表现的TAFRO综合征。
Clin Nephrol Case Stud. 2018 Jun 22;6:16-20. doi: 10.5414/CNCS109400. eCollection 2018.
8
Serial Manifestation of Acute Kidney Injury and Nephrotic Syndrome in a Patient with TAFRO Syndrome.TAFRO综合征患者急性肾损伤和肾病综合征的系列表现
Intern Med. 2018 Nov 1;57(21):3129-3133. doi: 10.2169/internalmedicine.0806-18. Epub 2018 Jun 6.
9
Clinicopathological features of progressive renal involvement in TAFRO syndrome: A case report and literature review.TAFRO综合征中进行性肾脏受累的临床病理特征:一例报告及文献复习
Medicine (Baltimore). 2017 Oct;96(40):e8216. doi: 10.1097/MD.0000000000008216.
10
Elevated serum interferon γ-induced protein 10 kDa is associated with TAFRO syndrome.血清干扰素诱导蛋白 10 kDa 升高与 TAFRO 综合征相关。
Sci Rep. 2017 Feb 13;7:42316. doi: 10.1038/srep42316.